FDA Warns Glaxo on Hypertension Drug Marketing
632138
The U.S. Food and Drug  Administration warned GlaxoSmithKline Plc  on Thursday over  misleading advertisements touting its hypertension drug called  Coreg.
307593
All studies to date provide inconsistent data about the potential contribution of GlaxoSmithKline Plc's diabetes drug Avandia to heart attack risk, the head of the Food and Drug Administration said in testimony prepared for a congressional hearing on Wednesday.
448573
A document released by the FDA outlines its concerns with GPC's lead drug.
743658
The U.S. Food and Drug Administration on Thursday ordered the review of preventative studies involving Pfizer Inc.'s painkillers Celebrex and Bextra, in light of recent evidence they may increase the risk of heart attack and stroke.
335523
US drug regulators are warning people not to buy or consume Actra-Rx or Yilishen, a Chinese product for improving men&#39;s sexual performance, because of potential risks.
492351
The U.S. Food and Drug  Administration on Monday issued a warning to patients taking  the painkiller naproxen after a government study showed the  over-the-counter medicine can cause an increased risk of heart  problems.
189822
The U.S. Food and Drug  Administration has warned Pfizer Inc.  that television and  print advertisements for its painkillers Celebrex and Bextra  misled consumers, according to a letter made public on  Wednesday.
323348
GlaxoSmithKline Plc fired another salvo in defense of diabetes treatment Avandia on Tuesday by taking out full-page advertisements in at least a dozen major U.S. newspapers in an attempt to reassure patients of the safety of the widely used medicine.
372735
Companies that make drugs to treat attention deficit hyperactivity disorder must take extra steps to alert patients to possible cardiovascular and psychiatric risks, U.S. health officials said on Wednesday.
16125
The Food and Drug Administration yesterday ordered a review of all prevention studies involving drugs such as Celebrex and Bextra, which have been associated with increased risk of heart problems. The agency also urged the public to limit use of over-the-counter pain medications.
744549
A pair of Food and Drug Administration advisory panels called yesterday for new warnings for the widely used diabetes drug Avandia because of evidence that it significantly raises the risk of heart attack, but they stopped short of recommending that the drug be pulled from the market, as some FDA...
386658
The U.S. Food and Drug Administration is facing new questions about its ability to police the safety of medicines after they reach the market following concerns about a widely used diabetes drug.
313927
The U.S. Food and Drug Administration on Wednesday ordered sleep disorder drugs to carry stronger warnings about their risks, such as drowsy driving and severe allergic reactions.
15642
NEW YORK, December 21  - The US Food and Drug Administration (FDA) warned today against the long-term usage of another arthritis drug, naproxen, after studies revealed increased risks of cardiovascular events.
604319
The Food and Drug Administration issued a warning to users of the over-the-counter pain reliever naproxen Monday after federal researchers found an increased number of heart attacks and strokes among users.
214931
A GlaxoSmithKline  blood pressure medicine proved significantly better in keeping blood sugar levels from rising in diabetics than another widely used member of the beta blocker family of hypertension drugs, according to a large clinical trial.
538035
Users of an anti-arthritis drug linked by a study to an increased risk of heart attacks and strokes have been urged not to panic. The UK Department of Health said users of Celebrex, manufactured by US drug